risk associated with investing the biotech industry. Wait until this latest euphoria dies downZero in on the few genomics firms that have a shot at becoming the next Amgen advises Robert Langreth of Forbes. That is obviously the best way to make money since the stock prices too high to buy now. There are three potential areas one can invest in when the time is right. Pharmaceutical companies such as Amgen or Human Genome Sciences are using gene databases to create new drugs. Both companies are bringing in profits, which is one step head on the competition. Data Miners are the companies that are mapping the genome. (Forbes) A company like Celera sells genome information to pharmaceutical companies. But it has been noted that there is not one company in existence that has made a consistent profit in doing so. There are also companies known as toolmakers, they design, build, and market devices to decode the genome. The devices can be microchips or software to read the genetic code. (Forbes) Lion Bioscience is only three and a half months old and investors and talking about it being the leader biotech software. Conclusion The Future is Now, thats what virtually every biotech company has plastered or implied on their respective web site. The vast improvements in technology has these companies and society excited. The old technologies are not going to disappear any time soon, the new ones will be better. So its just a matter of time until full implementation takes place. When it does, the biotech market will change, profits will be made and those who have money invested will also make a healthy profit....
